Significant evidence has highlighted the importance of aberrantly activated STAT3 signaling in a variety of cancers, including ovarian cancer cell lines and tissue samples, as detected by microarray analysis, real-time reverse transcription-PCR, Western blot, and the luciferase reporter assay [8,9,10]. This evidence concerns the gene STAT3 and ovarian cancer.